Noxopharm Limited announced earnings results for the full year ended June 30, 2021. For the full year, the company announced net loss was AUD 9.346 million compared to AUD 272,093 a year ago. Basic loss per share was AUD 0.0354 compared to AUD 0.002 a year ago. Basic loss per share from continuing operations was AUD 0.0354 compared to AUD 0.0752 a year ago.